The surface nano-coating developed by Advanced Endovascular Therapeutics increases the stent’s compatibility with blood and decreases the incidence of blood clot formation removing the need for dual antiplatelet drug therapy, hence solving the risk of hemorrhage present in existing treatments. The company’s technology has developed intracranial stents which can be used to treat ruptured aneurysms without the use of anti-platelet drugs. Three companies have expressed strong interest in the technology which will be licensed separately in order to reach patients

Venture Information
Stage: 
In formation
Industry: 
Medical Devices
Technology or Science Area: 
Surface nano-coating for stents used to treat brain aneurysms
Type of Product: 
medical Devices
Market: 
Endovascular treatment global market of cerebral aneurysms
Funding Round: 
Angel
Company Information
Founders: 
David Hasan